Stocks churned around the flatline to end the week with minor losses as a selloff in health care countered gains seen elsewhere. Drugmakers including Amgen (AMGN) and Bristol-Myers Squibb (BMY) were among the worst performers on Wall Street. Crude ended the day little changed even on more data of ballooning domestic production. The number of active oil rigs in the U.S. climbed by 14 in the past week, its ninth weekly gain in a row. Valeant Pharmaceuticals (VRX) fluctuated after ValueAct Capital increased its stake to just over 5%. The increase comes days after activist investor Bill Ackman and his company Pershing Square closed out their stake. SeaWorld (SEAS) fell after Citi analysts downgraded their rating to SELL. The firm said it sees increasing competition from Universal and that market estimates for earnings appear too high.
More from Video
How quickly do we find support, is what we'll want to know now, as the correction is occurring while economic optimism builds.
Despite the president's promise of no stimulus until after Nov. 3, there are no signs yet that this is the sort of correlated selling that leads to a deep correction.
Salesforce, Amgen and Honeywell will give a lift to the DJIA going forward.
CAG has hung onto the bulk of its recent gains, and could rise to the $50 area, according to the charts and indicators.